Brought to you by Digital Medicine Society, the leading global experts in digital health and medicine.
Coming soon Empowering healthcare delivery organizations with the power of AI
Search by your role
My Dashboard
Edit Account
The benefit set by the French Haute Autorité de Santé (HAS) is a criterion which takes into account: the seriousness of the pathology for which the medicine is indicated; and the data specific to the drug itself in a given indication.
Haute Autorité de Santé (HAS) | DiMe’s 3Ps of Digital Endpoint Value
Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients
Join the Integrated Evidence Plans project
Username or Email Address
Password
Remember Me
OR
